Land: Australien
Språk: engelska
Källa: Department of Health (Therapeutic Goods Administration)
Insulin lispro, Quantity: 100 IU/mL
Eli Lilly Australia Pty Ltd
Injection, suspension
Excipient Ingredients: zinc oxide; sodium hydroxide; hydrochloric acid; dibasic sodium phosphate heptahydrate; Protamine sulfate; phenol; glycerol; water for injections; metacresol
Subcutaneous
5 x cartridges
(S4) Prescription Only Medicine
For the treatment of patients with Type I (IDDM) and Type II (NIDDM) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
Visual Identification: White suspension.; Container Type: Cartridge; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
1999-10-08
HUMALOG ® , HUMALOG ® MIX25 AND HUMALOG ® MIX50 _CARTRIDGES_ _Insulin Lispro (rbe)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet is designed to provide you with answers to some common questions about these medicines. It does not contain all the available information and does not take the place of talking with your doctor. The information in this leaflet was last updated on the date shown on the final page. More recent information on this medicine may be available. Make sure you speak to your pharmacist, nurse or doctor to obtain the most up to date information on this medicine. You can also download the most up to date leaflet from www.lilly.com.au. The updated leaflet may contain important information about HUMALOG and its use that you should be aware of. All medicines have risks and benefits. Your doctor has more information about these medicines than is contained in this leaflet. Also, your doctor has had the benefit of taking a full and detailed history from you and is in the best position to make an expert judgement to meet your individual needs. IF YOU HAVE ANY CONCERNS ABOUT USING THESE MEDICINES, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT THE HUMALOG INSULINS ARE USED FOR HUMALOG insulins are used to reduce high blood sugar (glucose) levels in insulin dependent diabetic patients. Diabetes is a condition in which your pancreas does not produce enough insulin to control your blood sugar level. Extra insulin is therefore needed. There are two types of diabetes mellitus: Type 1 diabetes - also called Insulin Dependent Diabetes Mellitus (IDDM). Patients with type 1 diabetes always need insulin to control their blood sugar levels. Type 2 diabetes - also called Non insulin dependent diabetes mellitus (NIDDM). Some patients with type 2 diabetes may also need insulin after initial treatment with diet, exercise and tablets. HUMALOG insulins are insulin lispro, which works more quickly than soluble human insulin because the in Läs hela dokumentet
AUSTRALIAN PRODUCT INFORMATION vA12.0_Dec20 SUPERSEDES: vA11_Aug19 Page 1 of 15 HUMALOG ® [INSULIN LISPRO (RBE)] 10-ML VIAL HUMALOG ® CARTRIDGE [INSULIN LISPRO (RBE)] 3 ML HUMALOG ® KWIKPEN ® [INSULIN LISPRO (RBE)] 3 ML HUMALOG ® MIX25 ® CARTRIDGE [25% INSULIN LISPRO (RBE) AND 75% INSULIN LISPRO (RBE) PROTAMINE SUSPENSION] 3 ML HUMALOG ® MIX25 ® KWIKPEN ® [25% INSULIN LISPRO (RBE) AND 75% INSULIN LISPRO (RBE) PROTAMINE SUSPENSION] 3 ML HUMALOG ® MIX50 ® CARTRIDGE [50% INSULIN LISPRO (RBE) AND 50% INSULIN LISPRO (RBE) PROTAMINE SUSPENSION] 3 ML HUMALOG ® MIX50 ® KWIKPEN ® [50% INSULIN LISPRO (RBE) AND 50% INSULIN LISPRO (RBE) PROTAMINE SUSPENSION] 3 ML 1. NAME OF THE MEDICINE Insulin lispro (rbe) 2 AND 3. QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM The HUMALOG range consists of three presentations: HUMALOG - Insulin lispro solution [recombinant DNA origin] is an aqueous solution of insulin lispro ([Lys (B28), Pro (B29)] human insulin analogue, adjusted to pH 7.0 to 7.8. It also contains metacresol, glycerol, dibasic sodium phosphate heptahydrate, zinc oxide and water for injection. Hydrochloric acid and sodium hydroxide may be used to adjust pH. HUMALOG is available as a clear, colourless solution for parenteral administration in a concentration of 100 units/mL in 10-mL vials, 3-mL cartridges and 3-mL prefilled insulin delivery devices (HUMALOG KwikPen). HUMALOG MIX25 – 25% insulin lispro and 75% insulin lispro protamine suspension (NPL) [recombinant DNA origin] is a mixture of insulin lispro, a rapid-acting blood glucose lowering agent and insulin lispro protamine suspension, an intermediate-acting blood glucose lowering agent, adjusted to pH 7.0 to 7.8. vA12.0_Dec20 SUPERSEDES: vA11_Aug19 Page 2 of 15 HUMALOG MIX25 is available as a white suspension for parenteral administration in a concentration of 100 units/mL in 3 mL cartridges and 3 mL prefilled insulin delivery devices (HUMALOG MIX25 KwikPen). HUMALOG MIX50 –50% insulin lispro and 50% insulin lispro protamine suspensi Läs hela dokumentet